TOKYO -- Japanese pharmaceutical companies are ramping up efforts to develop cures for rare diseases. Progress in digital technology and generous government financial support are making such drugs increasingly lucrative.
Business trends
Japan's drugmakers look to orphan drugs to vie with Western rivals
Technology and government aid are improving viability of rare disease cures
Japanese pharmaceutical companies are looking to make inroads in developing cures for rare diseases, a field overlooked by companies in the U.S. and Europe. (Photo by Noriyuki Takada)
Read Next
Latest on Business trends
